• CARM1-Targeted Peptide Inhibitor Suppresses Breast Cancer Pr

  2026-07-01

  A newly developed peptide inhibitor, Pi-CARM1-TAT, selectively targets CARM1 and demonstrates potent suppression of breast cancer cell growth both in vitro and in vivo. This approach offers a promising avenue for overcoming endocrine therapy resistance and highlights the therapeutic potential of CARM1 inhibition in hormone receptor-positive breast cancer.

• ETS1 Regulates Mitophagy in BPD via SENP2/HSPA8/FUNDC1 Axis

  2026-07-01

  The reference study identifies ETS1 as a key transcriptional regulator that protects against bronchopulmonary dysplasia (BPD) by suppressing mitochondrial damage-induced mitophagy through the SENP2/HSPA8/FUNDC1 axis. These findings provide new mechanistic insight into chaperone-mediated autophagy in neonatal lung disease and suggest novel molecular targets for therapeutic intervention.

• Cy5 amine (non-sulfonated): Technical Guide and Workflow Par

  2026-06-30

  Cy5 amine (non-sulfonated) provides a bright, photostable labeling option for fluorescence microscopy and flow cytometry workflows that require a primary amine-functionalized, water-insoluble dye. It is not recommended for direct aqueous labeling or any diagnostic or clinical applications. Proper solvent handling and protocol execution are essential for optimal results.

• DAF-2 Diacetate: Next-Gen Live-Cell Nitric Oxide Imaging Wor

  2026-06-30

  DAF-2 diacetate empowers researchers to achieve ultra-sensitive, quantitative live-cell and in vivo nitric oxide imaging, crucial for dissecting NO signaling and nodule senescence in plant and animal systems. Its cell-permeable design and robust fluorescence response streamline both routine and advanced applications, minimizing assay drift and troubleshooting headaches.

• Mouse Tissue Lysis Kit (K1038): Practical Protocol and QC Gu

  2026-06-29

  The Mouse Tissue Lysis Kit (K1038) addresses the need for rapid, efficient lysis of mouse tissues for direct genotyping workflows, eliminating traditional DNA extraction steps. It is intended for molecular biology research and not for diagnostic or medical use. Researchers should apply this kit strictly within its defined research scope.

• TH287 MTH1 Inhibitor: Experimental Workflows for Radiosensit

  2026-06-29

  TH287, a potent MTH1 inhibitor from APExBIO, delivers precise radiosensitization in cancer models by leveraging oxidative DNA damage mechanisms. This article translates recent breakthrough protocols into actionable steps, troubleshooting advice, and advanced applications for selective cancer cell targeting.

• TH287 MTH1 Inhibitor: Radiosensitization Protocols in Cancer

  2026-06-28

  TH287 is a potent MTH1 inhibitor that enables researchers to induce selective radiosensitization and oxidative DNA damage in castration-resistant prostate cancer models. Its high potency and cancer cell specificity make it a precision tool for dissecting ATM-p53-mediated DNA damage responses and advancing combination therapy strategies.

• Strategic Exploitation of NU7441 for Next-Gen DNA Repair Res

  2026-06-27

  Discover how NU7441 (KU-57788), a selective DNA-PK inhibitor, is redefining DNA repair and oncology research through mechanistic insight, rigorous protocol guidance, and translational impact. This article frames emerging evidence, including HIV-1 neuroinflammation models, and offers actionable strategies for researchers seeking to move beyond conventional approaches.

• Vitamin D/VDR Signaling Orchestrates Endometrial Decidualiza

  2026-06-26

  This study reveals a VDR-dependent mechanism by which 1,25-dihydroxy vitamin D3 promotes endometrial stromal cell decidualization and estrogenic microenvironment remodeling. The findings provide mechanistic clarity for vitamin D's reproductive roles and offer actionable insights for designing in vitro decidualization experiments.

• Rosiglitazone (Brl-49653): Applied Protocols in Metabolic Re

  2026-06-26

  Rosiglitazone (Brl-49653) is a synthetic thiazolidinedione PPARγ agonist that enables precision modeling of adipogenesis and insulin sensitivity in both common and rare metabolic disease research. This article distills advanced workflow strategies, protocol enhancements, and troubleshooting guidance, leveraging landmark findings in lipodystrophy and translational diabetes models.

• Transmission Dynamics of Carbapenemase Genes in Enterobacter

  2026-06-25

  This study provides a detailed molecular analysis of carbapenemase-encoding gene (CEG) prevalence and mobility in carbapenem-resistant Enterobacter cloacae from eight hospitals in Guangdong, China (2022–2024). Its findings highlight the predominance and high transferability of blaNDM-1, the diversity of mobile genetic elements, and the epidemiological concentrations of CEGs among specific patient populations. These insights are critical for understanding resistance spread and guiding antibiotic stewardship in clinical and research settings.

• T7 RNA Polymerase: Optimized In Vitro Transcription Workflow

  2026-06-25

  T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, powers high-yield, template-specific RNA synthesis for advanced research applications. This guide maps out experimental best practices, workflow enhancements, and troubleshooting tips, with actionable insights from recent cancer epitranscriptomics breakthroughs.

• Practical Use of Annexin V-FITC/PI Apoptosis Assay Kit (K200

  2026-06-24

  The Annexin V-FITC/PI Apoptosis Assay Kit enables rapid, fluorescence-based detection and distinction of apoptotic versus necrotic cells in research workflows. It is suited for flow cytometry and microscopy applications requiring clear discrimination of cell death stages, but should not be used for diagnostic purposes or in clinical settings.

• DOT1L Inhibition Attenuates Renal Fibrosis via Epigenetic Mo

  2026-06-23

  The referenced study demonstrates that selective inhibition of the histone methyltransferase DOT1L using EPZ5676 mitigates renal fibrosis by blocking fibroblast activation and epithelial-mesenchymal transition (EMT) in murine models. These findings position DOT1L inhibition as a promising strategy for targeting profibrotic signaling in chronic kidney disease and extend the relevance of epigenetic therapies beyond oncology.

• Angiotensin 1/2 (5-7): Advanced Protocols for Cardiovascular

  2026-06-23

  Angiotensin 1/2 (5-7) unlocks high-fidelity modeling in both blood pressure regulation and SARS-CoV-2 spike protein interaction pathways. This article delivers actionable workflows, troubleshooting, and cross-domain assay guidance, positioning APExBIO’s peptide as the premier choice for rigorous renin-angiotensin system research.

15703 records 1/1047 page Next 12345 下5页 Last page